1. Validation of the Novel European Society of Cardiology 0/2-hour Algorithm Using Hs-cTnT in the Early Diagnosis of Myocardial Infarction.
- Author
-
Wildi K, Lopez-Ayala P, Koechlin L, Boeddinghaus J, Nestelberger T, Wussler D, Carigiet M, Giménez MR, Miró Ò, Sanchez FJM, Strebel I, Gualandro DM, Twerenbold R, and Mueller C
- Subjects
- Aged, Early Diagnosis, Emergency Service, Hospital, Female, Humans, Male, Middle Aged, Myocardial Infarction blood, Myocardial Infarction diagnosis, Non-ST Elevated Myocardial Infarction blood, Reproducibility of Results, Time Factors, Triage, Non-ST Elevated Myocardial Infarction diagnosis, Troponin T blood
- Abstract
Competing Interests: Conflict of Interest Dr. Wildi has received research funding from the FAG Basel (Freiwillige Akademische Gesellschaft), the Julia und Gottfried Bangerter-Rhyner-Stiftung, the Prince Charles Hospital Foundation, The Wesley Medical Research Foundation and the CRE Action fund (NHMRC). In addition, she received a PhD scholarship from the University of Queensland. Dr. Mueller has received research support from the Swiss National Science Foundation, the Swiss Heart Foundation, the KTI, the European Union, the University of Basel, the University Hospital Basel, the Stiftung für kardiovaskuläre Forschung Basel; Abbott, Beckman Coulter, Biomerieux, Idorsia, Ortho Cinical Diagnostics, Quidel, Roche, Siemens, Singulex, Sphingotec, as well as speaker honoraria and/or consulting honoraria from Acon, Amgen, Astra Zeneca, Boehringer Ingelheim, Bayer, BMS, Idorsia, Novartis, Osler, Roche, Sanofi, outside of the submitted work. All other authors declare no conflicts of interest.
- Published
- 2021
- Full Text
- View/download PDF